Luca Quagliata
Private Equity Investor bij Xgen Venture Sgr SpA
Profiel
Dr Luca Quagliata joined XGEN as Venture Partner in 2023.
Luca is VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific.
Before joining Thermo Fisher, Luca worked as Senior Director and Team Leader of the Molecular Diagnostics Division at the Institute of Pathology, University Hospital Basel, Switzerland.
Luca is trained in Medical Biotechnology (Naples, Italy), holds a Ph.D.
in Vascular Medicine (Heidelberg, Germany), a Certificate of Achievement (COA) in Genetics (Harvard, Boston), was a visiting fellow at the NCI-NIH (Bethesda, USA), and is a Board-Certified Specialist in Medical Affairs (BCMAS).
Actieve functies van Luca Quagliata
Bedrijven | Functie | Begin |
---|---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 01-01-2023 |
Opleiding van Luca Quagliata
Heidelberg University (Ohio) | Doctorate Degree |
Università degli Studi di Napoli Federico II | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |